The private equity fund EQT has sold the Danish nicotine chewing gum manufacturer Fertin Pharma to Philip Morris International for DKK 5.1bn.
Fertin Pharma is a leading player within the manufacture of nicotine chewing gum. In addition, the company manufactures dietary supplements, cannabinoids etc. which, much like nicotine, are delivered to the consumer through chewing gum or tablets.
In 2016, EQT bought 70% of Fertin Pharma from the Bagger-Sørensen family.
Philip Morris International is a multinational tobacco manufacturer that sells products in more than 180 countries. One of the company’s brands is Marlboro.
The transaction is subject to approval from the authorities.
Accura advised EQT in connection with the transaction.